Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/

Details Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/ Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/

1987-08-04

1990-11-13

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514568, A61K 3134, A61K 3119

Patent

active

049702335

ABSTRACT:
There is disclosed a method of treating inflammatory viral infections of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/LAV virus and Acquired Immunodeficiency Syndrome (AIDS) Related Complex (ARC) in humans by stimulating and increasing the rate of Prostaglandin Biosynthesis to levels many times higher than that now occurring naturally thereby enhancing and reconstituting the Immune System, comprising the oral administration of an effective dosage of 3,3-Bis(p-hydroxyphenyl) phthalide (phenolphthalein) by itself or in composition with, or in combination with a Prostaglandin Synthetase inhibitor Aspirin or Indomethacin. Comprising the oral administration of an effective dosage of 3,3-Bis(p-hydroxyphenyl) phthalide (phenolphthalein) by itself or in composition with, or in combination with a Prostaglandins Synthetase inhibitor Aspirin or Indomethacin.

REFERENCES:
patent: 4256763 (1981-03-01), McHugh
patent: 4588744 (1986-05-01), McHugh

Affiliated with

Also associated with

Rating

Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-777201